4.5 Review

Platelets, circulating tumor cells, and the circulome

Journal

CANCER AND METASTASIS REVIEWS
Volume 36, Issue 2, Pages 235-248

Publisher

SPRINGER
DOI: 10.1007/s10555-017-9681-1

Keywords

Circulome; Liquid biopsy; Circulating tumor cells; CTC; Colorectal cancer; Tumor-educated platelets; cfDNA

Categories

Funding

  1. Boone Pickens Distinguished Chair for Early Prevention of Cancer, Duncan Family Institute, Colorectal Cancer Moon Shot [P30CA016672-41, 1R01CA187238-01, 5R01CA172670-03, 1R01CA184843-01A1, CA177909]

Ask authors/readers for more resources

Platelets are cytoplasmic fragments generated by megakaryocytes in the bone marrow and do not possess a nucleus. They contribute to the Circulome consisting of all circulating cells, factors and macromolecules such as cfDNA. Their primary function is to recognize vascular lesions and initiate thrombus formation that ceases bleeding. This distinctive characteristic of platelets also contributes to cancer and its progression. The ability of platelets to recognize and interact with other cells and neighboring platelets enables them to interact with tumor cells in the circulation. Receptor recognition and factor mediated crosstalk between tumor cells and platelets stimulate platelet activation, release of factors, and aggregation that promotes tumor cell survival and cancer progression. This review describes platelet: (i) contributions to the Circulome (ii) their importance as diagnostic tools in predicting cancer risk and (iii) therapies targeting platelet activation in inhibiting tumor progression and metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available